<table id="_Reftable7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7:          Percent Increase of Rivaroxaban PK and PD Parameters from Normal in Subjects with Renal Insufficiency from a Dedicated Renal Impairment Study</caption>
<col width="33%"></col>
<col width="7%"></col>
<col width="20%"></col>
<col width="20%"></col>
<col width="20%"></col>
<thead>
<tr>
<th align="left" colspan="2" stylecode="Toprule " valign="top"></th>
<th align="left" colspan="3" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">CrCl (mL/min)</content>
</th>
</tr>
<tr>
<th align="left" colspan="2" stylecode="Botrule " valign="top">
<content stylecode="bold">Parameter</content>
</th>
<th align="left" stylecode="Botrule " valign="top">
<content stylecode="bold">50 to 79</content>
<br/>
<content stylecode="bold">N = 8</content>
</th>
<th align="left" stylecode="Botrule " valign="top">
<content stylecode="bold">30 to 49</content>
<br/>
<content stylecode="bold">N = 8</content>
</th>
<th align="left" stylecode="Botrule " valign="top">
<content stylecode="bold">15 to 29</content>
<br/>
<content stylecode="bold">N = 8</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="5" stylecode="Botrule" valign="top">PT = Prothrombin time; FXa = Coagulation factor Xa; AUC = Area under the concentration or effect curve; C<sub>max </sub>= maximum concentration; E<sub>max </sub>= maximum effect; and CrCl = creatinine clearance</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Toprule " valign="top">
<paragraph>
<content stylecode="bold">Exposure</content>
</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>
<content stylecode="bold">AUC</content>
</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>44</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>52</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>64</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>
<content stylecode="bold">(% increase relative to normal)</content>
</paragraph>
</td>
<td valign="top">
<paragraph>
<content stylecode="bold">C<sub>max</sub>
</content>
</paragraph>
</td>
<td valign="top">
<paragraph>28</paragraph>
</td>
<td valign="top">
<paragraph>12</paragraph>
</td>
<td valign="top">
<paragraph>26</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>
<content stylecode="bold">FXa Inhibition</content>
</paragraph>
</td>
<td valign="top">
<paragraph>
<content stylecode="bold">AUC</content>
</paragraph>
</td>
<td valign="top">
<paragraph>50</paragraph>
</td>
<td valign="top">
<paragraph>86</paragraph>
</td>
<td valign="top">
<paragraph>100</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>
<content stylecode="bold">(% increase relative to normal)</content>
</paragraph>
</td>
<td valign="top">
<paragraph>
<content stylecode="bold">E<sub>max</sub>
</content>
</paragraph>
</td>
<td valign="top">
<paragraph>9</paragraph>
</td>
<td valign="top">
<paragraph>10</paragraph>
</td>
<td valign="top">
<paragraph>12</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>
<content stylecode="bold">PT Prolongation</content>
</paragraph>
</td>
<td valign="top">
<paragraph>
<content stylecode="bold">AUC</content>
</paragraph>
</td>
<td valign="top">
<paragraph>33</paragraph>
</td>
<td valign="top">
<paragraph>116</paragraph>
</td>
<td valign="top">
<paragraph>144</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule " valign="top">
<paragraph>
<content stylecode="bold">(% increase relative to normal)</content>
</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>
<content stylecode="bold">E<sub>max</sub>
</content>
</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>4</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>17</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>20</paragraph>
</td>
</tr>
</tbody>
</table>